يعرض 81 - 90 نتائج من 308 نتيجة بحث عن '"Philipp Le Coutre"', وقت الاستعلام: 1.48s تنقيح النتائج
  1. 81
    Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

    المؤلفون: Neil P. Shah, Philip A. Rowlings, Jorge E. Cortes, François Xavier Mahon, Kyna Gooden, Philipp le Coutre, Glenn S. Kroog, Jiří Mayer, Giuseppe Saglio, Milayna Subar

    المصدر: Annals of hematology, vol 96, iss 8
    Annals of Hematology

    مصطلحات موضوعية: Oncology, Male, Outcome Assessment, Dasatinib, Cardiorespiratory Medicine and Haematology, Cardiovascular, 0302 clinical medicine, Prednisone, Ischemia, hemic and lymphatic diseases, Outcome Assessment, Health Care, Antineoplastic Combined Chemotherapy Protocols, Ischemic, Medicine, Chronic, Clinical Trials as Topic, Leukemia, Incidence (epidemiology), Incidence, Chronic myeloid leukemia, Hematology, General Medicine, Middle Aged, Docetaxel, Cardiovascular Diseases, 030220 oncology & carcinogenesis, Original Article, Female, medicine.drug, Adult, medicine.medical_specialty, Immunology, Placebo, 03 medical and health sciences, Outcome Assessment (Health Care), Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, Risk factor, Intensive care medicine, Protein Kinase Inhibitors, Aged, Tyrosine kinase inhibitors, business.industry, Prostatic Neoplasms, Imatinib, Clinical trial, Health Care, BCR-ABL Positive, business, 030215 immunology, Myelogenous

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65800c0b628baa5f98ecc1e11eafcdeeTest
    https://escholarship.org/uc/item/1361k75xTest


    أضف إلى المفضلة
  2. 82
    Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study

    المؤلفون: Philipp le Coutre, Steven Novick, Michele Baccarani, Francis J. Giles, Helene Santanastasio, Mimi Leung, Andreas Reiter, Hagop M. Kantarjian, Martin C. Müller, Andreas Hochhaus

    المصدر: Journal of Cancer Research and Clinical Oncology

    مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Neutrophils, Anemia, Original Article – Clinical Oncology, Tyrosine kinase inhibitor, Neutropenia, Systemic mastocytosis, Gastroenterology, Leukocyte Count, Mastocytosis, Systemic, Internal medicine, medicine, Humans, Adverse effect, Protein Kinase Inhibitors, Indolent systemic mastocytosis, Aggressive systemic mastocytosis, Aged, Retrospective Studies, Myeloproliferative Disorders, business.industry, General Medicine, Middle Aged, Protein-Tyrosine Kinases, Nilotinib, medicine.disease, Discontinuation, Proto-Oncogene Proteins c-kit, Pyrimidines, Treatment Outcome, Oncology, Immunology, Absolute neutrophil count, Female, business, KIT D816V, Progressive disease, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381606d9fee12d95447c3edf4581b51aTest
    https://doi.org/10.1007/s00432-015-1988-0Test


    أضف إلى المفضلة
  3. 83
    Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors

    المؤلفون: Peter Valent, Emir Hadzijusufovic, Gerit-Holger Schernthaner, Dominik Wolf, Philipp le Coutre, Delphine Rea

    المصدر: Blood. 125:901-906

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Immunology, Fusion Proteins, bcr-abl, Pharmacology, Biochemistry, chemistry.chemical_compound, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Vascular Diseases, Adverse effect, Protein Kinase Inhibitors, ABL, business.industry, Ponatinib, Myeloid leukemia, Imatinib, Cell Biology, Hematology, Dasatinib, chemistry, Nilotinib, business, Tyrosine kinase, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae983f672256399bbc68434cf339d47Test
    https://doi.org/10.1182/blood-2014-09-594432Test


    أضف إلى المفضلة
  4. 84
    BCR-ABL1+ Acute Myeloid Leukemia: Clonal Selection of a BCR-ABL1- Subclone as a Cause of Refractory Disease with Nilotinib Treatment

    المؤلفون: Jörg Westermann, Seval Türkmen, Renate Arnold, Michaela Schwarz, Bernd Dörken, Philipp Hemmati, Philipp le Coutre, Thomas Burmeister, Christiane Bommer, Nina Rosa Neuendorff

    المصدر: Acta Haematologica. 133:237-241

    مصطلحات موضوعية: Myeloid, business.industry, Clone (cell biology), Myeloid leukemia, Hematology, General Medicine, Disease, medicine.disease, Philadelphia chromosome, humanities, Leukemia, medicine.anatomical_structure, Nilotinib, hemic and lymphatic diseases, Immunology, Cancer research, Medicine, business, medicine.drug, Clonal selection

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b98fdb28c02958dc5597851f469fde87Test
    https://doi.org/10.1159/000368176Test


    أضف إلى المفضلة
  5. 85
    Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia

    المؤلفون: Philipp le Coutre, Heike Pfeifer, Nicola Gökbuget, Marion Nagy, Renate Arnold, P.G. Hemmati, Theis H. Terwey, Monika Brüggemann, Tanja Melinh Le Duc, Bernd Dörken

    المصدر: Biology of Blood and Marrow Transplantation. 20:1522-1529

    مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Neoplasm, Residual, Transplantation Conditioning, Adolescent, medicine.medical_treatment, Hematopoietic stem cell transplantation, Acute lymphoblastic leukemia, Chimerism, Bone Marrow, Recurrence, hemic and lymphatic diseases, Internal medicine, Humans, Transplantation, Homologous, Medicine, Cumulative incidence, Relapse, Retrospective Studies, Transplantation Chimera, Transplantation, business.industry, Minimal residual disease, Incidence (epidemiology), Stem cell transplantation, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Myeloablative Agonists, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, Survival Analysis, Highly sensitive, Surgery, body regions, Treatment Outcome, Adult Acute Lymphoblastic Leukemia, Female, Stem cell, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bac1842098732eff2bda0971bc4b00Test
    https://doi.org/10.1016/j.bbmt.2014.05.026Test


    أضف إلى المفضلة
  6. 86
    Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase:ENEST1st sub-analysis

    المؤلفون: Maria Liz Paciello Coronel, Beatrice Vincenzi, Ljubomir Petrov, Fausto Castagnetti, Delphine Rea, Andrzej Hellmann, Francis J. Giles, Andreas Hochhaus, Valentin Garcia-Gutierrez, Maria Asuncion Echeveste Gutierrez, Franҫois-Xavier Mahon, Luca Dezzani, Philipp le Coutre, Gianantonio Rosti, Norbert Gattermann, Nicholas C.P. Cross, Jeroen Janssen

    المساهمون: CCA - Cancer Treatment and quality of life, Hematology, Hochhaus, Andrea, Mahon, Franois-Xavier, le Coutre, Philipp, Petrov, Ljubomir, Janssen, Jeroen J. W. M., Cross, Nicholas C. P., Rea, Delphine, Castagnetti, Fausto, Hellmann, Andrzej, Rosti, Gianantonio, Gattermann, Norbert, Coronel, Maria Liz Paciello, Gutierrez, Maria Asuncion Echeveste, Garcia-Gutierrez, Valentin, Vincenzi, Beatrice, Dezzani, Luca, Giles, Francis J.

    المصدر: Hochhaus, A, Mahon, F-X, le Coutre, P, Petrov, L, Janssen, J J W M, Cross, N C P, Rea, D, Castagnetti, F, Hellmann, A, Rosti, G, Gattermann, N, Coronel, M L P, Gutierrez, M A E, Garcia-Gutierrez, V, Vincenzi, B, Dezzani, L & Giles, F J 2017, ' Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase : ENEST1st sub-analysis ', Journal of Cancer Research and Clinical Oncology, vol. 143, no. 7, pp. 1225-1233 . https://doi.org/10.1007/s00432-017-2359-9Test
    Journal of Cancer Research and Clinical Oncology
    Journal of Cancer Research and Clinical Oncology, 143(7), 1225-1233. Springer Verlag
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid

    مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Myeloid, Original Article – Clinical Oncology, Fusion Proteins, bcr-abl, Gastroenterology, Antineoplastic Agent, 0302 clinical medicine, hemic and lymphatic diseases, Philadelphia Chromosome, Hematology, Chronic myeloid leukemia, Myeloid leukemia, General Medicine, Middle Aged, Leukemia, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Female, Human, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Anemia, Philadelphia Chromosome Negative, Protein Kinase Inhibitor, Antineoplastic Agents, Real-Time Polymerase Chain Reaction, Philadelphia chromosome, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, Philadelphia chromosome negative/BCR-ABL positive, Protein Kinase Inhibitors, Aged, ENEST1st, business.industry, Nilotinib, medicine.disease, Pyrimidines, 030104 developmental biology, Pyrimidine, business, Multiplex Polymerase Chain Reaction

    وصف الملف: STAMPA; application/pdf; text

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32a0b316372c1eb5fd4577816af80c2Test
    https://research.vumc.nl/en/publications/0d7cc258-28f1-462e-bdd2-52e52f3fc3b9Test


    أضف إلى المفضلة
  7. 87
    Nilotinib 300 mg BID as frontline treatment of CML: Prospective analysis of the Xpert BCR-ABL Monitor system and significance of 3-month molecular response

    المؤلفون: Mary Frances McMullin, Michael O'Dwyer, Eibhlin Conneally, Philipp le Coutre, Ronan T. Swords, Alberto Alvarez-Iglesias, Francis J. Giles, Arnon Nagler, Richard C. Woodman, Stephen E. Langabeer, Hongxin Fan

    المصدر: Leukemia Research. 38:310-315

    مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Pathology, Neoplasm, Residual, Fusion Proteins, bcr-abl, Phases of clinical research, Antineoplastic Agents, Real-Time Polymerase Chain Reaction, Drug Administration Schedule, Prospective analysis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Prospective Studies, Aged, Likelihood Functions, ABL, business.industry, Hematology, Middle Aged, Molecular diagnostics, Minimal residual disease, Pyrimidines, Treatment Outcome, Real-time polymerase chain reaction, Nilotinib, Molecular Response, Female, Drug Monitoring, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f69f6842c64cff6d19c4413cb660c72fTest
    https://doi.org/10.1016/j.leukres.2013.11.016Test


    أضف إلى المفضلة
  8. 88
    Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission

    المؤلفون: Philipp Hemmati, Renate Arnold, Bernd Dörken, Lam G. Vuong, Theis H. Terwey, Philipp le Coutre, Anthea Schulze-Luckow

    المصدر: European Journal of Haematology. 92:102-110

    مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Transplantation Conditioning, Multivariate analysis, Adolescent, Karyotype, Graft vs Host Disease, Subgroup analysis, Young Adult, Internal medicine, medicine, Humans, Transplantation, Homologous, Prospective Studies, Aged, business.industry, Incidence (epidemiology), Remission Induction, Hazard ratio, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Hematology, General Medicine, Middle Aged, Prognosis, Surgery, Transplantation, Leukemia, Myeloid, Acute, Treatment Outcome, Female, Stem cell, business, Follow-Up Studies, Monosomal karyotype

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1775c662c512354ca06665b3a3ce3858Test
    https://doi.org/10.1111/ejh.12216Test


    أضف إلى المفضلة
  9. 89
    5-Year Updates from the Pivotal Phase 2 Ponatinib PACE Trial: Efficacy, Safety and Landmark Analysis in Heavily Pretreated Patients with Chronic-Phase Chronic Myeloid Leukemia

    المؤلفون: Franck E. Nicolini, Martin C. Mueller, Timothy P. Hughes, Tim Clackson, Moshe Talpaz, Philipp le Coutre, Sergio Santillana, Michael W. Deininger, Victor M. Rivera, Javier Pinilla-Ibarz, Michele Baccarani, Stephanie Lustgarten, Charles Chuah, Ronald Paquette, Hagop M. Kantarjian, Andreas Hochhaus, Jorge E. Cortes, Neil P. Shah

    المصدر: Clinical Lymphoma Myeloma and Leukemia. 17:S307-S308

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Ponatinib, Hematology, Chronic phase chronic myeloid leukemia, Phase (combat), chemistry.chemical_compound, Oncology, chemistry, Landmark analysis, Medicine, business, Intensive care medicine

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5e3eb0b2a28a0291a681824e83404648Test
    https://doi.org/10.1016/j.clml.2017.07.105Test


    أضف إلى المفضلة
  10. 90
    Imatinib Suspension and Validation (ISAV) Study: Final Results at 79 Months

    المؤلفون: Eros Di Bona, Bruno Martino, Silvia Mori, Philipp le Coutre, Alessandra Pirola, Patrizia Crivori, Ester Pungolino, Chiara Elena, Rocco Piazza, Alessandra Iurlo, Micaela Bergamaschi, Marcio M Andrade, Carlo Gambacorti-Passerini, Maria Luisa Bonanomi, Elisabetta Abruzzese, Sarit Assouline, Dong-Wook Kim, Fabio Stagno, Antonella Gozzini, Michela Luciani

    المصدر: Blood. 132:461-461

    مصطلحات موضوعية: medicine.medical_specialty, Intention-to-treat analysis, business.industry, Nausea, 05 social sciences, Immunology, Imatinib, Cell Biology, Hematology, Biochemistry, Minimal residual disease, Discontinuation, 03 medical and health sciences, 0302 clinical medicine, Imatinib mesylate, Quality of life, 030220 oncology & carcinogenesis, Internal medicine, 0502 economics and business, medicine, 050211 marketing, medicine.symptom, business, Sokal Score, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::55b550c8e39028523281a33ce943237aTest
    https://doi.org/10.1182/blood-2018-99-112982Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث